IMAX (NYSE: IMAX) insider transactions
In the twelve months to 10 November 2026, executives and directors of IMAX reported 27 open-market sales of 1,634,693 shares ($70.3m) and 0 open-market purchases, by 8 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 10 September 2026 | Lister Robert D | Chief Legal Officer Sr Exec VP | Open-market sale | −22,500 | $51.58 | 182,375 | Form 4 |
| 25 August 2026 | Weissman Kenneth Ian | Deputy GC, Corp. Sec. & CCO | Open-market sale | −8,000 | $54.54 | 28,205 | Form 4 |
| 25 August 2026 | Welton Mark | President IMAX Global Theatres | Open-market sale | −30,000 | $54.47 | 143,216 | Form 4 |
| 24 August 2026 | Fernandes Natasha | Chief Financial Officer & EVP | Open-market sale | −20,000 | $54.63 | 35,596 | Form 4 |
| 20 August 2026 | Pablo Calamera | CTO & EVP | Open-market sale | −15,000 | $52.41 | 43,012 | Form 4 |
| 20 August 2026 | Gelfond Richard L | Chief Executive Officer | Open-market sale, 10b5-1 plan | −100,000 | $53.23 | 665,002 | Form 4 |
| 19 August 2026 | Gelfond Richard L | Chief Executive Officer | Conversion, 10b5-1 plan | +205,504 | $31.90 | 970,506 | Form 4 |
| 19 August 2026 | Gelfond Richard L | Chief Executive Officer | Open-market sale, 10b5-1 plan | −205,504 | $53.27 | 765,002 | Form 4 |
| 18 August 2026 | Gelfond Richard L | Chief Executive Officer | Conversion, 10b5-1 plan | +151,253 | $31.90 | 916,255 | Form 4 |
| 18 August 2026 | Gelfond Richard L | Chief Executive Officer | Open-market sale, 10b5-1 plan | −151,253 | $51.00 | 765,002 | Form 4 |
| 6 August 2026 | Zlatar Jose Aleksandr | SVP, Controller & PAO | Open-market sale | −500 | $49.90 | 583 | Form 4 |
| 11 June 2026 | Douglas James E Iii | — | Grant or award | +3,390 | — | 3,660,840 | Form 4 |
| 11 June 2026 | Leebron David W | Director | Option exercise | +3,390 | — | 131,083 | Form 4 |
| 11 June 2026 | Berman Gail | Director | Option exercise | +3,390 | — | 22,582 | Form 4 |
| 11 June 2026 | Pamon Steve | Director | Option exercise | +3,390 | — | 35,515 | Form 4 |
| 11 June 2026 | Wong Jennifer L. | Director | Option exercise | +3,390 | — | 22,582 | Form 4 |
| 11 June 2026 | Settle Dana R | Director | Option exercise | +3,390 | — | 69,090 | Form 4 |
| 11 June 2026 | Demirian Eric A | Director | Option exercise | +3,390 | — | 40,483 | Form 4 |
| 11 June 2026 | Demirian Eric A | Director | Shares withheld for tax | −1,842 | $42.12 | 38,641 | Form 4 |
| 11 June 2026 | MacMillan Michael | Director | Option exercise | +3,390 | — | 41,418 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the IMAX page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.